This SuperSeries is composed of the SubSeries listed below.
hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy.
Cell line, Treatment, Time
View SamplesThe goal of this experiment was to identify possible genes affected directly or indirectly by anti-miR-191.
hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy.
Cell line, Treatment
View SamplesLuminal, basal, stromal, and endothelial cells were MACS sorted from whole tissue. Targets from five biological replicates of each were generated and the expression profiles were determined using Affymetrix U133 Plus 2.0 arrays. These data represent cell specific transcriptomes.
Transcriptomes of human prostate cells.
No sample metadata fields
View SamplesNo description.
No associated publication
Sex, Specimen part, Cell line, Treatment
View SamplesRNAseq of YAC128 mice treated with pridopidine
No associated publication
Sex, Age, Specimen part, Cell line, Treatment
View SamplesFACS RNAseq of transgenic lines pWUS and pYAB
No associated publication
Specimen part
View SamplesRaw sequence reads are provided for RNA-seq of parental and transgenerational worms in which the P0 were treated with OP50 (control) or PA14.
No associated publication
Sex, Specimen part, Cell line
View SamplesIdentifying transcriptional changes in adults, whose biology and behavior differsubstantially from developing animals, is important when evaluating adult phenotypes.Moreover, cell- and tissue-specific information is critical for understanding the biologyof multicellular animals. We used adult cell-specific isolation to identify thetranscriptomes of C. elegans'' major adult tissues (muscle, intestine, epidermis, andneurons).
No associated publication
Sex, Specimen part, Cell line
View SamplesWe evaluated the therapeutic activity of the modified U1 particles in a mouse model affected by severe spinal muscular atrophy. ExSpeU1 introduced by germline transgenesis efficiently rescued the phenotype increasing SMN2 exon 7 splicing, SMN protein production and radically extending the life span.
No associated publication
Sex, Age, Specimen part, Disease, Cell line
View SamplesRegulatory T-cells (Treg) play an essential role in the negative regulation of immune answers by developing an attenuated cytokine response that allows suppressing proliferation and effector function of T-cells (CD4+ Th). The transcription factor FoxP3 is responsible for the regulation of many genes involved in the Treg gene signature. Its ablation leads to severe immune deficiencies in human and mice. Recent developments in sequencing technologies have revolutionized the possibilities to gain insights into transcription factor binding by ChiP-Seq and into transcriptome analysis by mRNA-Seq. We combine FoxP3 ChiP-Seq and mRNA-Seq in order to understand the transcriptional differences between primary human CD4+ T helper and regulatory T-cells, as well as to study the role of FoxP3 in generating those differences. We show, that mRNA-Seq allows analyzing the transcriptomal landscape of T-cells including the expression of specific splice variants at much greater depth than previous approaches, whereas 50% of transcriptional regulation events have not been described before by using diverse array technologies.
Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human.
No sample metadata fields
View Samples